SK Biopharmaceuticals Establishes Radiopharmaceuticals Division...Carries Out 2026 Organizational Restructuring
Choi Yoonjung Appointed as Head of Strategy Division
On December 4, SK Biopharmaceuticals announced that it has carried out an organizational restructuring for 2026, including the establishment of a Radiopharmaceuticals Division.
This restructuring was implemented to proactively respond to the changing global business environment and to strengthen core functions and execution capabilities centered on future growth drivers. The changes will take effect on January 1 of next year.
To accelerate the radiopharmaceuticals (RPT) business, which has emerged as a future growth modality, the company established the RPT Division. The RPT Division is an organization equipped with end-to-end operational functions, including securing raw materials and isotopes, discovering and conducting preclinical development of pipelines, and global business development. By establishing the Radiopharmaceuticals Division, the company aims to foster the RPT business as a core growth driver.
In addition, as the importance of future strategic direction and execution has increased, Choi Yoonjung, who has led the existing Business Development Division, has been appointed as Head of the Strategy Division. The Strategy Division will integrate the company’s core decision-making functions, including establishing mid- to long-term company-wide strategies, managing the business portfolio, promoting global growth strategies, and reviewing new businesses, thereby enhancing the alignment and speed of future strategy execution.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Through this organizational restructuring, SK Biopharmaceuticals plans to strengthen its competitiveness in the global market and solidify its foundation for balanced growth in new drug development and new businesses.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.